de Haan G, Dontje B, Loeffler M, Nijhof W
Laboratory of Physiological Chemistry, University of Groningen, The Netherlands.
Br J Haematol. 1993 Sep;85(1):15-9. doi: 10.1111/j.1365-2141.1993.tb08639.x.
We administered recombinant human IL-1 beta (400 ng/d, s.c.) for 10 d to normal C57B1 mice and determined daily granuloid and erythroid parameters in marrow, spleen and blood. In the marrow CFU-GM numbers were not affected but later granuloid cell stages were moderately enhanced (170%). In the spleen, however, CFU-GM numbers were sharply increased (1600%), whereas the granuloid precursors only doubled. Blood granulocytes increased transiently to 275% on day 5. In the marrow all erythroid parameters were severely reduced. This reduction was partially compensated by the spleen where initially only BFU-E and with some delay also more mature erythroid cells accumulated. At the end of the treatment mice were slightly anaemic. When mice were treated with IL-1 and erythropoietin (10 U/d) simultaneously, the inhibitory effects on erythropoiesis were less severe. In agreement with in vivo results, IL-1 inhibited in vitro colony growth of CFU-E from normal bone marrow and spleen but spleen CFU-E from 5 d IL-1 treated mice were insensitive. We conclude that IL-1 can induce stimulation or inhibition of haemopoietic progenitor cells depending on their microenvironment.
我们给正常的C57B1小鼠皮下注射重组人白细胞介素-1β(400 ng/天),持续10天,并测定骨髓、脾脏和血液中每日粒细胞和红细胞参数。骨髓中CFU-GM数量未受影响,但后期粒细胞阶段适度增强(170%)。然而,脾脏中CFU-GM数量急剧增加(1600%),而粒细胞前体细胞仅增加一倍。血液粒细胞在第5天短暂增加至275%。骨髓中所有红细胞参数均严重降低。这种降低在脾脏中得到部分补偿,最初脾脏中只有BFU-E,且有一定延迟,更成熟的红细胞也开始积累。治疗结束时小鼠出现轻度贫血。当小鼠同时接受白细胞介素-1和促红细胞生成素(10 U/天)治疗时,对红细胞生成的抑制作用不那么严重。与体内结果一致,白细胞介素-1抑制正常骨髓和脾脏中CFU-E的体外集落生长,但来自接受白细胞介素-1治疗5天的小鼠的脾脏CFU-E不敏感。我们得出结论,白细胞介素-1可根据造血祖细胞的微环境诱导刺激或抑制作用。